Kestra Advisory Services’s GSK GSK Stock Holding History

Kestra Advisory Services’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.39M	Buy	61,375 +5,797	+10%	+$314K	0.01%	997
2025 Q4	$2.73M	Buy	55,578 +5,445	+11%	+$254K	0.01%	1044
2025 Q3	$2.16M	Buy	50,133 +4,301	+9%	+$168K	0.01%	1103
2025 Q2	$1.76M	Buy	45,832 +11,636	+34%	+$445K	0.01%	1143
2025 Q1	$1.32M	Sell	34,196 -13,391	-28%	-$490K	0.01%	1213
2024 Q4	$1.61M	Sell	47,587 -114,849	-71%	-$4.13M	0.01%	1117
2024 Q3	$6.64M	Sell	162,436 -16,846	-9%	-$689K	0.04%	498
2024 Q2	$6.9M	Buy	179,282 +116,647	+186%	+$4.91M	0.04%	483
2024 Q1	$2.69M	Buy	62,635 +22,551	+56%	+$930K	0.02%	761
2023 Q4	$1.49M	Sell	40,084 -14,905	-27%	-$535K	0.01%	945
2023 Q3	$1.99M	Sell	54,989 -1,317	-2%	-$46.7K	0.02%	684
2023 Q2	$2.01M	Buy	56,306 +5,248	+10%	+$188K	0.02%	671
2023 Q1	$1.82M	Sell	51,058 -15,102	-23%	-$528K	0.02%	686
2022 Q4	$2.32M	Sell	66,160 -3,614	-5%	-$120K	0.02%	687
2022 Q3	$2.05M	Buy	69,774 +5,507	+9%	+$209K	0.02%	656
2022 Q2	$3.5M	Buy	64,267 +6,549	+11%	+$362K	0.04%	470
2022 Q1	$3.14M	Sell	57,718 -1,024	-2%	-$55.6K	0.03%	523
2021 Q4	$3.24M	Sell	58,742 -30,326	-34%	-$1.58M	0.03%	516
2021 Q3	$4.25M	Buy	89,068 +12,342	+16%	+$620K	0.04%	444
2021 Q2	$3.82M	Buy	76,726 +315	+0.4%	+$15.1K	0.04%	432
2021 Q1	$3.41M	Sell	76,411 -46,997	-38%	-$2.13M	0.04%	429
2020 Q4	$5.71M	Buy	123,408 +52,840	+75%	+$2.43M	0.07%	300
2020 Q3	$3.32M	Buy	+70,568	New	+$3.54M	0.06%	313

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Kestra Advisory Services's GSK Position: Q1 2026 in Review

Kestra Advisory Services increased its GSK (GSK) stake by 10% in Q1 2026, buying an estimated $314K and bringing the position to 61,375 shares worth $3.39M. The position accounts for 0.01% of the portfolio, ranked #997.

Kestra Advisory Services first reported a position in GSK in Q3 2020 and has held it in 23 quarters since. The position peaked at $6.9M in Q2 2024. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Kestra Advisory Services held 61,375 shares of GSK worth $3.39M as of Q1 2026.
Kestra Advisory Services bought 5,797 GSK shares in Q1 2026, an estimated $314K.
GSK made up 0.01% of Kestra Advisory Services's portfolio in Q1 2026, its #997 holding.
Kestra Advisory Services first reported a position in GSK in Q3 2020 and has held it in 23 quarters since.
Kestra Advisory Services's GSK position peaked at $6.9M in Q2 2024.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.